Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EAN 2020 | When and how to stop DBS in late-stage Parkinson’s disease?

Margherita Fabbri • 15 May 2020
EAN 2020
Movement Disorders Parkinson's Disease Levodopa

Margherita Fabbri, MD, PhD, University of Toulouse, Toulouse, France, discusses when and how to stop subthalamic deep brain stimulation (DBS) in late-stage Parkinson’s Disease (PD). This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Margherita Fabbri

2:54
An overview on late-stage Parkinson’s disease
Margherita Fabbri • 17 Sep 2022
1:08
The symptomatic management of Parkinson’s disease
Margherita Fabbri • 17 Sep 2022
1:06
COMT inhibitors for Parkinson’s disease: clinical updates
Margherita Fabbri • 17 Sep 2022
1:15
Clinical trials in atypical parkinsonism
Margherita Fabbri • 17 Sep 2022

Related Videos

5:26
Pridopidine shows benefit for patients with early HD not on antidopaminergic therapies
Michael Hayden • 16 Apr 2024
2:51
Overlap in etiology between different FND subtypes
Mark Hallett • 15 Apr 2024
1:58
Ambroxol & other targeted therapies in Parkinson's
K Ray Chaudhuri • 21 Mar 2024
3:00
The use of precision medicine in Parkinson’s disease
K Ray Chaudhuri • 21 Mar 2024
The content of VJNeurology is intended for healthcare professionals